G. Lang

发表

Polo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancer.

Emmanuel Barillot, Anne Vincent-Salomon, Guillem Rigaill, 2013, Cancer research.

A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing.

H. Stunnenberg, S. Kato, L. Tora, 2008, Molecular cell.

Molecular Biology of Papilloma Virus

P. Fuchs, H. Pfister, G. Lang, 1987 .

Characterization of a novel T lymphocyte protein which binds to a site related to steroid/thyroid hormone receptor response elements in the negative regulatory sequence of the human immunodeficiency virus long terminal repeat.

M. Collins, D. Latchman, G. Lang, 1992, Nucleic acids research.

The Tightly Controlled Deubiquitination Activity of the Human SAGA Complex Differentially Modifies Distinct Gene Regulatory Elements

L. Tora, D. Umlauf, Krishanpal Karmodiya, 2011, Molecular and Cellular Biology.

Stable growth transformation of human T lymphocytes by herpesvirus saimiri.

R. Desrosiers, B. Fleckenstein, I. Müller-Fleckenstein, 1992, Proceedings of the National Academy of Sciences of the United States of America.

trans activation of the thymidylate synthase promoter of herpesvirus saimiri

B. Fleckenstein, G. Lang, 1990, Journal of virology.

Therapeutics , Targets , and Chemical Biology Polo-like Kinase 1 : A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer

E. Barillot, A. Vincent-Salomon, S. Roman-Roman, 2013 .

PLK 1 as a therapeutic target in triple-negative breast cancer 1 1 Polo-like kinase 1 : a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancer

E. Barillot, A. Vincent-Salomon, S. Roman-Roman, 2012 .

A palindromic element in the human immunodeficiency virus long terminal repeat binds retinoic acid receptors and can confer retinoic acid responsiveness on a heterologous promoter.

M. Collins, D. Latchman, J. Harris, 1993, Journal of Acquired Immune Deficiency Syndromes.

Targeting Bcl-2/Bcl-XL Induces Antitumor Activity in Uveal Melanoma Patient-Derived Xenografts

L. Desjardins, S. Piperno-Neumann, S. Depil, 2014, PloS one.

A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing.

H. Stunnenberg, S. Kato, L. Tora, 2008, Molecular cell.